In-vitro Toxicology Testing Market To Be Driven By Significant Advancements In Toxicology Science during 2021 - 2028

In-vitro Toxicology Testing Industry Overview 

The global in-vitro toxicology testing market size was estimated at USD 22.7 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 10.7% from 2021 to 2028.

Significant advancements in toxicology science are one of the primary factors driving the market. Also, high costs associated with conventional animal tests and socio-ethical concerns associated with animal tests are anticipated to boost the growth of the market for in-vitro toxicology testing. 

As in-vitro toxicology studies can help in minimizing liabilities related to late-stage failure in the drug discovery process, a high number of research studies and drug development programs for COVID-19 are expected to accelerate the market for in-vitro toxicology testing. More than 590 drugs for COVID-19 are in the development program as of November 2020. Such a high number of drug development programs is anticipated to boost the demand for in vitro toxicology testing services. 

Gather more insights about the market drivers, restrains and growth of the Global In-vitro Toxicology Testing Market

 Significant advancements in in-vitro toxicology assays to evaluate drug product safety along with the assessment of the potential effect of pharmaceuticals on cells and tissues are anticipated to bolster revenue generation in the market. With an increase in the need for such assays, companies have broadened their portfolio to serve demand in the market for in-vitro toxicology testing. 

Availability of different methods in biotechnology and bioinformatics division to carry out in-silico simulation on animal models is also attributive for influencing industry growth through to 2028. Moreover, the development of toxicology databases for in-silico analysis of different compounds is anticipated to fuel demand for in-vitro techniques thereby leading to sector progress. 

Considerable government funding for research coupled with definite reimbursement policies to develop automated and technologically advanced equipment for laboratory analysis and ex-vivo studies is expected to enhance market stability. On the contrary, unavailability of immunity testing and immune stimulation in current in-vitro tests is expected to hamper the growth of this industry. 

Browse through Grand View Research's Biotechnology Industry Research Reports. 

  • Biotechnology Market - The global biotechnology market size was valued at USD 752.88 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 15.83% from 2021 to 2028. The market is driven by favorable government initiatives owing to the growth of the biotechnology sector in developing countries, such as India and China. Government initiatives are oriented towards modernizing the drug regulatory pathway, standardizing clinical studies, improving reimbursement policies, and speeding up the product approval process. 
  • Bioinformatics Market - The global bioinformatics market size was valued at USD 3.51 billion in 2013. Growing demand in the process of novel drug R&D and private and public funding initiatives to support R&D exercises are expected to be the key factors driving the market during the forecast period.

 In-vitro Toxicology Testing Market Segmentation 

Grand View Research has segmented the global in-vitro toxicology testing market on the basis of end-use, technology, method, application, and region: 

  • In-vitro Toxicology Testing End-use Outlook (Revenue, USD Million, 2018 - 2028)
    • Pharmaceutical Industry
    • Cosmetics & Household Products
    • Academic Institutes and Research Laboratories
    • Diagnostics
    • Chemical Industry
    • Food Industry
  • In-vitro Toxicology Testing Technology Outlook (Revenue, USD Million, 2018 - 2028)
    • Cell Culture Technology
    • High Throughput Technology
    • Molecular Imaging
    • OMICS Technology
  • In-vitro Toxicology Testing Application Outlook (Revenue, USD Million, 2018 - 2028)
    • Systemic Toxicology
    • Dermal Toxicity
    • Endocrine Disruption
    • Occular toxicity
    • Others
  • In-vitro Toxicology Testing Method Outlook (Revenue, USD Million, 2018 - 2028)
    • Cellular Assay
      • Live Cells
        • High Throughput / High Content Screening
        • Molecular Imaging
          • Confocal Microscopy
          • Others
        • Others
      • Fixed Cells
    • Biochemical Assay
    • In-Silico
    • Ex-vivo
  • In-vitro Toxicology Testing Regional Outlook (Revenue, USD Million, 2018 - 2028)
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East & Africa (MEA) 

Market Share Insights 

  • August 2019: Abbott signed an agreement with Intoximeters, which gave Intoximeters exclusive distribution rights to Abbott's SoToxa Mobile Test System, a handheld oral fluid solution for drugs and alcohol testing in the U.S. The product enables the testing of methamphetamine, benzodiazepines, amphetamine, cocaine, cannabis (THC), and opiates. 
  • November 2019: The U.S. National Institute for Environmental Health Sciences planned to provide funds to small companies for the development of engineered 3D culture or organotypic culture models (OCM) in-vitro systems. 

Key Companies profiled: 

Some prominent players in the global in-vitro toxicology testing market include

  • Merck KGaA
  • Charles River
  • Bio-Rad Laboratories, Inc.
  • Abbott
  • Thermo Fisher Scientific Inc.
  • Catalent, Inc.
  • GE Healthcare
  • Quest Diagnostics Incorporated
  • Eurofins Scientific
  • Laboratory Corporation of America Holdings
  • Evotec
  • Creative Bioarray
  • Gentronix
  • BioIVT
  • SGS SA
  • Agilent Technologies 

Order a free sample PDF of the In-vitro Toxicology Testing Market Intelligence Study, published by Grand View Research.

 

 

Comments

Post a Comment

Popular posts from this blog

Cell Culture Industry Is Projected To Boost Due To Growing Adoption For Drug Development, Tissue Engineering, And Biopharmaceuticals Manufacturing

Cell culture industry data book covers cell culture, cell culture media, 3d cell culture, primary cell culture market. Cell culture industry  data book is a combination of the market data from four reports namely, cell culture, cell culture media, 3D cell culture, and primary cell culture market. Cell culture market was valued at USD 21.05 Billion in 2021 with CAGR of 11.86% during 2022-2030. Cell culture media market and primary cell culture market are also growing at the CAGR of 12.13% and 10.66% respectively. Grand View Research’s Cell Culture Industry databook is a collection of market sizing & forecasts insights, market dynamics & trends, opportunity assessment, regulatory & technology framework, pricing intelligence, competitive benchmarking analyses, macro-environmental analyses studies. Within the purview of the databook, such information is systematically analyzed and provided in the form of summary presentations and detailed outlook reports on individual areas of
Read more

Scaffold Technology Market To Grow As Of Rising Demand For 3D Cellular Models In Biological Studies And Translational Research

Image
    Scaffold Technology Industry Overview   The global  scaffold technology market  size is expected to reach USD 2.1 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 8.4% from 2021 to 2028. The market growth can be primarily attributed to the growing popularity of bioprinting for mimicking the tissue microenvironment in printed 3D tissue models. The need to expand the horizon of multidisciplinary research areas has supplemented the adoption of scaffold technologies in 3D printed models.   Scaffold Technology Market Segmentation Grand View Research has segmented the global scaffold technology market based on type, application, disease type, end-use, and region:   Based on the  Type  Insights, the market is segmented into Hydrogels, Wound Healing, 3D Bioprinting, Immunomodulation. The hydrogels emerged as a dominant segment and accounted for the largest revenue share of 42.2% in 2020. Ongoing technological advancements
Read more

Stem Cells Industry To Be Driven By The Growth In The Number Of Cell Therapy Production Facilities And Expansion In The Number Of Clinical Trials

Image
      Stem cells industry data book covers human embryonic stem cells, induced pluripotent stem cells production, mesenchymal stem cells, stem cells and cancer stem cells market. Grand View Research’s  Stem Cells Industry  databook is a collection of market sizing & forecasts insights, market dynamics & trends, opportunity assessment, regulatory & technology framework, pricing intelligence, competitive benchmarking analyses, and macro-environmental analysis studies. Within the purview of the databook, such information is systematically analyzed and provided in the form of summary presentations and detailed outlook reports on individual areas of research. The following data points will be included in the final product offering in five reports and one sector report overview.   Human Embryonic Stem Cells Market Insights The human embryonic stem cells market was valued at USD 1.10 Billion in 2022 with a CAGR of 10.6% during 2023-2030. These are the pluripotent cells that posses
Read more